BCBS Reaches $2.8 Billion Settlement to Resolve Antitrust …
Dec 17, 2024 · Blue Cross Blue Shield (BCBS) – with 33 of its member companies – recently reached a proposed settlement, agreeing to pay $2.8 billion to settle allegations that BCBS plans violated antitrust laws by suppressing competition and underpaying providers for reimbursements from July 2008 to October 2024.This class action proposed settlement represents the largest …
CVS Subsidiary Reaches $60 Million Settlement Over False Claims …
Nov 11, 2024 · Oak Street Health, a wholly-owned subsidiary of CVS Health since 2023, has agreed to pay $60 million to resolve allegations that it violated the False Claims Act (FCA) by paying kickbacks to third party insurance agents in exchange for their recruiting of seniors to Oak Street Health’s primary care clinics.. The United States alleged that prior to CVS’ ownership, in …
Teva Pharmaceuticals Fined €462.6 Million Over Anti-Competitive ...
Nov 5, 2024 · On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its market dominance by delaying competition for Copaxone, a leading multiple sclerosis treatment.This case marks a pivotal decision as it addresses both patent misuse and disparagement, two strategies that Teva allegedly …
Walgreens Reaches $106.8 Million False Claims Act Settlement …
Nov 14, 2024 · Walgreens Boots Alliance Inc. and Walgreen Co. (collectively, “Walgreens”) agreed to pay $106.8 million in two settlements (here and here) to resolve allegations that Walgreens violated the False Claims Act and various state statutes when billing government health care programs for prescriptions that were never dispensed to patients.According to the …
January 8, 2025 – Policy & Medicine
Jan 8, 2025 · 2025 will be a busy year for healthcare. Here is a list of healthcare conferences and links to registration. Special thanks to…
What a Trump Presidency Could Mean for the Life Sciences Industry
Nov 8, 2024 · Trump’s priorities to fix the Affordable Care Act (ACA) mark a significant shift in the healthcare landscape. His return to office may bring renewed efforts to modify or repeal certain ACA provisions, including allowing states greater flexibilities in defining essential health benefits, limiting the individual and employer mandates, and reducing spending on Medicaid block grants.
Minnesota’s 340B Program Report Sheds Light on Potential …
Dec 2, 2024 · The Minnesota Department of Health recently unveiled a pivotal report on the 340B drug pricing program, which provides insight into how the program’s financial benefits are being utilized by non-profit hospitals and clinics.The 340B program was originally designed to help these facilities purchase medications at significantly reduced prices to support patient care for the …
The Inflation Reduction Act (IRA) and Its Broader ... - Policy
On October 8, 2024, PhRMA held a media briefing to address growing concerns over the Inflation Reduction Act (IRA) and its effects on the biopharmaceutical industry, Medicare Part D beneficiaries, and future drug innovations. Leading the discussion w
2025 – Policy & Medicine
Jan 2, 2025 · Welcome to another edition of our weekly roundup, where we dive into the most pressing legal, regulatory, and policy updates that…
January 3, 2025 – Policy & Medicine
Jan 3, 2025 · Legal, Regulatory, and Compliance Issues. ASD Specialty Healthcare LLC, trading as Besse Medical, has reached a $1.67 million settlement to resolve allegations of violating…